KRAS and intrahepatic cholangiocarcinoma: The presence of KRAS variation was a negative independent prognostic factor for survival and recurrence in patients with ICC, which is consistent with previous findings.5,6 We found that this prognostic value was mainly owing to G12 KRAS variants because non-G12 KRAS variants demonstrated no significant association with prognosis.